October 22, 2017 8:26 AM ET


Company Overview of Liaoning Haisco Pharmaceutical Co., Ltd.

Company Overview

Liaoning Haisco Pharmaceutical Co., Ltd. manufactures pharmaceuticals. The company offers various drugs, including nalmefene hydrochloride injection, dolasetron mesylate injection, cefodizime sodium for injection, hydroxyethyl starch 200/0.5 and sodium chloride injection, medium and long chain fat emulsion injection(C8-24), and compound amino acids injection (18AA-VII). The company was founded in 2005 and is based in Xingcheng, China. Liaoning Haisco Pharmaceutical Co., Ltd. operates as a subsidiary of Haisco Pharmaceutical Group Co., Ltd.

Xingcheng,  125107


Founded in 2005

Key Executives for Liaoning Haisco Pharmaceutical Co., Ltd.

Liaoning Haisco Pharmaceutical Co., Ltd. does not have any Key Executives recorded.

Recent Private Companies Transactions

April 1, 2017
Shenyang Haisco Pharmaceutical Co., Ltd.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Liaoning Haisco Pharmaceutical Co., Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.